In today's zero-tolerance drug safety environment, pharmacovigilance has never been more important. To ensure patient safety, minimize costs and assure compliance, life sciences firms must aggressively detect and manage emerging safety risks.
Cognizant provides solutions that enable long-term success. Our consultants address evolving issues related to drug safety and process consistency, such as new compliance requirements and can integrate safety data from disparate sources. We also help you explore the latest IT platforms leveraging the cloud, analytics and mobile computing.
To face growing challenges, Pharmacovigilance leaders must focus on collaboration, globalization and transparency. This white paper outlines five forces driving improved business outcomes.
Many pharmaceutical companies still have inefficient drug safety operations, resulting in higher costs and undermining efforts to significantly increase overall performance. This white paper outlines Cognizant’s approach.